CMS Releases (CMS-1738-F) Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Final Rule

Published in Government Relations on December 22, 2021

Long-awaited with keen interest by industry stakeholders, CMS released on December 21, 2021 its final rule (CMS-1738-F) relative to post-pandemic DMEPOS fee schedule adjustments, in addition to making certain benefit category and payment determinations for new items, classification of adjunctive continuous glucose monitors as DME under Medicare Part B and finalized certain DME payment provisions that were included in two interim final rules (CMS-1687-F and CMS-5531-F).

However, the main focus and concerns to DME suppliers, were, arguably, the final methodology of fee schedule payment “adjustment” amounts for DME furnished in rural, non-competitive bidding areas (non-CBAs) and CBAs on or after April 1, 2021 or the date immediately following the duration of the public health emergency period (PHE), or whichever was later. 

More than 100 industry comments were received by the agency. 

Background:  On October 27, 2020, CMS issued a proposed rule with the purpose to establish methodologies for adjusting the fee schedule amounts noted above. Under this proposal, CMS would continue paying suppliers higher rates for furnishing items and services in rural (and non-contiguous areas, i.e. Alaska and Hawaii with the exception of metropolitan Honolulu) as compared to items and services furnished in other areas, informed by stakeholder input indicating higher costs in these areas, greater travel distances and costs in certain non-CBAs compared to CBAs.  CMS acknowledged “the unique logistical challenges and costs of furnishing items to beneficiaries in the non-contiguous areas, significantly lower volume of items furnished in these areas versus CBAs, and concerns about financial incentives for suppliers in surrounding urban areas to continue including outlying rural areas in their service areas.” Previous feedback from industry stakeholders expressed concern regarding beneficiary access to items and services furnished in rural and remote areas.  For items that were included in Round 2021, but were removed from Round 2021 of the program, the agency also considered whether to simply extend application of the current fee schedule adjustment rules for non-CBAs and for CBAs and former CBAs until new single payment amounts (SPAs) were calculated for the items once competitive bidding of the items has been resumed.

The Final Rule DMEPOS Fee Schedule Adjustments

  • CMS will continue paying suppliers the 50/50 blend[1] of adjusted and unadjusted fee schedule rates for furnishing items and services in rural and non-contiguous areas. The agency commented “these rates were informed by stakeholder input”, as noted above.  “CMS will continue to monitor payments in rural and non-contiguous areas and all non-CBAs, as well as health outcomes, assignment rates, and other information, and may also consider our payment methodologies toward DMEPOS items and services furnished in rural and non-contiguous areas and non-CBAs in the context of any future changes to the DMEPOS CBP.”
     
  • The CARES Act required the calculation of new, higher fee schedule amounts for certain items furnished in non-rural contiguous non-CBAs based on a blend of 75 percent of the adjusted fee schedule amount and 25 percent of the unadjusted fee schedule amount for the duration of the PHE.  However, this Final Rule does not extend the “75/25” blend after the pandemic is declared over[2].  “For contiguous, non-rural areas, CMS will be paying suppliers 100 percent of the adjusted fee schedule rates using information from the DMEPOS CBP. For the former CBAs, CMS will be paying the single payment amounts (SPAs) established during DMEPOS CBP updated by an inflation adjustment factor on an annual basis” …effectively these areas will revert to the previous Regional Single Payment Amount (RSPA)[3]
     
  • For 2022, “this final rule does not change these already existing payment methodologies” in former CBAs…effectively allowing no increase in payment (ostensibly until the next round of bidding), with the exception of a 5 percent inflation update.  (The non-CBA blended fees will receive between 5.1% - the unadjusted fee update, and 5.4% - the adjusted fee update).

Other Final Rule Issues (abridged)

  • The agency is finalizing conforming technical changes to the regulations text to exclude infusion drugs from the DMEPOS CBP.
     
  • This final rule establishes procedures for making benefit category determinations and payment determinations for new DMEPOS, therapeutic shoes and inserts, surgical dressings, or splints, casts, and other devices used for reductions of fractures and dislocations under Medicare Part B that permit public consultation through public meetings.
     
  • The final rule classifies adjunctive continuous glucose monitors (CGMs) under the Medicare Part B benefit for DME. However, CMS is not finalizing the proposed categories of supplies and accessories and fee schedule amounts for three types of CGM systems.
     
  • CMS is not finalizing its proposals regarding (1) the submission and evaluation of Healthcare Common Procedure Coding System (HCPCS) Level II code applications and (2) the proposed revision to our interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.
     
  • Please review the CMS Fact Sheet and the Federal Register  (pdf) to access the entire document. 

The Final Rule fee schedule provisions are effective at end of the PHE.  Additional analysis and commentary will follow from VGM.  Questions or comments, please contact Mark Higley, Vice-President Regulatory Affairs, at mark.higley@vgm.com or 319.504.9515

Analysis and commentary from John Gallagher

Now with the DMEPOS Final Rule finally out, and the fact that the Final Rule has not deviated that much from the CMS Proposed Rule… The Industry can move forward with our Champions - Rep. Cathy McMorris-Rodgers (R-WA), Rep. Markwayne Mullin (R-OK) and Rep. Paul Tonko (D-NY) on Energy & Commerce to bring forth legislative language to address;

  • Legislation that will provide additional relief to HME providers particularly those that service patients outside of competitive bidding areas in Non-Rural Areas -  by extending the Cares Act 75/25 Blend at least through the next round of CBP in 2023/24.
     
  • Legislation to extend the Non-Rural Blended Rate – 75/25 to those of Competitive Bidding Areas (CBA).  Just because a beneficiaries zip code is in Boise or any other Competitive Bid Area, they should not be subjected to access issues due to no relief with a blended rate.
     
  • Legislation that will correct/improve the competitive bidding program.  Currently, the next round of Competitive Bid is unlikely until at least 2024 - if then.  In the meantime Providers are stuck with Competitive Bid Rates from 2016. With supply Chain / inflationary issues those rates are unattainable until CMS figures out what they plan to do.  CMS has failed with the Competitive Bidding Program on three different bids.  Congress needs to step in and direct CMS with a workable Competitive Bidding Auction system that works. The industry / VGM has been working on just such an alternative auction with Dr. Ken Brown and the Economics Department at Missouri State University.

Moving into 2022, the Government Relations and Regulatory team will continue to fight for accessibility and fair reimbursement for quality goods and services. We hope you will join us.

Cheers to a productive 2022!  

John E. Gallagher
Vice President
VGM Government Relations and Regulatory Affairs


[1] Section 3712(a) of the CARES Act extended the current adjusted fee schedule methodology that pays for certain items furnished in rural and non-contiguous non-CBAs based on a 50/50 blend of adjusted and unadjusted fee schedule amounts through December 31, 2020 or through the duration of the PHE, whichever was later.

[2] Section 3712(b) of the CARES Act mandates that the fee schedule amounts for these same items furnished in all other non-competitive bidding areas be based on a 75/25 blend of adjusted and unadjusted fee schedule amounts through the duration of the PHE.

[3] Section 1834(a)(1)(F) of the Social Security Act requires the CMS to adjust fee schedule amounts for DME after January 1, 2016, in areas where CBPs are not in place for these items based on information from the CBPs.

The adjustments to the fee schedule amounts for most items furnished in the contiguous United States are based on the average of single payment amounts from CBPs located within the geographic region of the country where the State is located. The contiguous United States is divided into eight geographic regions based on the eight regions established by the Federal Bureau of Economic Analysis (BEA) for the purpose of conducting economic analyses. These regional single payment amounts (RSPAs) are then limited by a national floor and a national ceiling based on 90 percent and 110 percent of the average of the RSPAs.


TAGS

  1. cms
  2. medicare

From Our Experts

Featuring Two Champions Of Change: Robert Beard of YD Home Medical & Rob Minicucci Jr. of Health System Services thumbnail Featuring Two Champions Of Change: Robert Beard of YD Home Medical & Rob Minicucci Jr. of Health System Services Today, we're proud to spotlight two outstanding durable medical equipment (DME) champions whose advocacy efforts are making a meaningful difference: Robert Beard of YD Home Medical of Alabama and Rob Minicucci Jr. of Health System Services of New York. These individuals took time out of their busy schedules to personally connect with elected officials, demonstrating how local action can spark national change. Survey: Share Your Thoughts on Proposed Accreditation Rule Changes thumbnail Survey: Share Your Thoughts on Proposed Accreditation Rule Changes CQRC, VGM, and AAHomecare are requesting your feedback on a new proposed rule that could significantly impact accreditation procedures. Under the proposal, accreditation organizations would be required to conduct site visits every year—a major shift from the current once-every-three-years schedule. WEBINAR: Navigating New CMS Guidelines: Unlocking Opportunities in NIPPV and RAD Coverage for COPD Care thumbnail WEBINAR: Navigating New CMS Guidelines: Unlocking Opportunities in NIPPV and RAD Coverage for COPD Care The Centers for Medicare & Medicaid Services (CMS) has revised the NCD for Noninvasive Positive Pressure Ventilation (NIPPV) in the home setting for treating Chronic Respiratory Failure (CRF) due to Chronic Obstructive Pulmonary Disease (COPD). The changes aim to establish clear coverage policies for devices such as Respiratory Assist Devices (RADs) and home mechanical ventilators (HMVs), potentially expanding access to these critical therapies for eligible patients. Adapting to new CMS guidelin Bipartisan Medicare O&P Bill Introduced thumbnail Bipartisan Medicare O&P Bill Introduced In a timely move ahead of next week's NAAOP Legislative Fly-In, a bipartisan group of lawmakers introduced the Medicare Orthotics and Prosthetics Patient-Centered Care Act, a bill aimed at improving access to high-quality orthotic and prosthetic care for Medicare beneficiaries. The Patient-Centered Care Act seeks to address critical gaps in Medicare coverage for orthotic and prosthetic (O&P) services. Under current rules, beneficiaries may receive devices without the necessary clinical services Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu